This inventor holds 1 USPTO granted patent. Top assignee: Osaka University. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Masatomo So: Innovator in Neurodegenerative Disease Diagnosis
Introduction
Masatomo So is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of neurodegenerative diseases, particularly in the diagnosis of conditions such as Parkinson's disease and multiple system atrophy. His innovative approach has the potential to improve diagnostic accuracy and patient outcomes.
Latest Patents
Masatomo So holds a patent for a method and kit designed to discriminate between Parkinson's disease and multiple system atrophy. The patent outlines a method that includes several steps: preparing a solution containing α-synuclein monomers that have a tendency to produce rod-like aggregates and/or twisted aggregates, adding a biological sample from a subject to the solution, allowing the α-synuclein monomers to aggregate, and finally detecting the α-synuclein aggregates formed during the process. This innovative method represents a significant advancement in the diagnostic capabilities for these complex diseases. He has 1 patent to his name.
Career Highlights
Masatomo So is affiliated with Osaka University, where he conducts research and develops innovative solutions in the field of neurodegenerative diseases. His work has garnered attention for its potential impact on clinical practices and patient care.
Collaborations
Masatomo So has collaborated with notable colleagues, including Hideki Mochizuki and Keita Kakuda. These collaborations have contributed to the advancement of research in neurodegenerative diseases and have fostered a productive academic environment.
Conclusion
Masatomo So's contributions to the field of neurodegenerative disease diagnosis highlight the importance of innovation in medical research. His patented method for distinguishing between Parkinson's disease and multiple system atrophy showcases his commitment to improving patient outcomes through scientific advancement.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
